Population differences in immune responses to bacille calmette- guérin vaccination in infancy

Journal of Infectious Diseases

Volumn 199, Issue 6, 2009, Pages 795-800

  Lalor, Maeve K ^a,b   Ben Smith, Anne ^a,d   Gorak Stolinska, Patricia ^a   Weir, Rosemary E ^a   Floyd, Sian ^b   Blitz, Rose ^a   Mvula, Hazzie ^d   Newport, Melanie J ^c   Branson, Keith ^b   McGrath, Nuala ^b   Crampin, Amelia C ^b,d   Fine, Paul E M ^b   Dockrell, Hazel M ^a  

^a Immunology Unit   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

^d KARONGA PREVENTION STUDY   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE; DROLOXIFENE; GAMMA INTERFERON; MYCOBACTERIUM TUBERCULOSIS PURIFIED PROTEIN DERIVATIVE; TUBERCULIN; UNCLASSIFIED DRUG;

ARTICLE; BCG VACCINATION; BIRTH WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; INFANCY; INFANT; MALAWI; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; PRIORITY JOURNAL; SEASONAL VARIATION; TUBERCULOSIS; UNITED KINGDOM;

BCG VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA; MYCOBACTERIUM TUBERCULOSIS; VACCINATION;

EID: 65649085586     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597069     Document Type: Article

References (15)

1. World Health Organization (WHO).WHOvaccine-preventable disease monitoring system, 2006 global summary: global and regional summary, BCG. Available at: http://www.who.int/immunization-monitoring/diseases/GS-BCG.pdf. Accessed 3 February 2008.
2. Department of Health. Changes to the BCG vaccination programme in England. London, UK: Department of Health Publications, 2005.
3. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346:1339-45.
4. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993; 22:1154-8.
5. Black GF, Weir RE, Floyd S, et al. BCG-induced increase in interferon- response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002; 359:1393-401.
6. Black GF, Dockrell HM, Crampin AC, et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis 2001; 184: 322-9.
7. Weir RE, Gorak-Stolinska P, Floyd S, et al. Persistence of the immune response induced by BCG vaccination. BMC Infect Dis 2008; 8:9.
8. Weir RE, Fine PE, Nazareth B, et al. Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin Exp Immunol 2003; 134:285-94.
9. Diness BR, Fisker AB, Roth A, et al. Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine. Am J Clin Nutr 2007; 86:1152-9.
10. Weir RE, Black GF, Nazareth B, et al. The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to Bacille Calmette-Guerin vaccination in southern England and northern Malawi. Clin Exp Immunol 2006; 146:390-9.
11. Vekemans J, Amedei A, Ota MO, et al. Neonatal bacillus Calmette- Guerin vaccination induces adult-like IFN-gamma production by CD4- T lymphocytes. Eur J Immunol 2001; 31:1531-5.
12. Murray RA, Mansoor N, Harbacheuski R, et al. Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8- T cell response. J Immunol 2006; 177:5647-51.
13. Moore SE, Collinson AC, Fulford AJ, et al. Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan. Trop Med Int Health 2006; 11:1529-41.
14. Miles DJ, van der Sande M, Crozier S, et al. Effects of antenatal and postnatal environments on CD4 T-cell responses to Mycobacterium bovis BCG in healthy infants in the Gambia. Clin Vaccine Immunol 2008; 15:995-1002.
15. Bennett AR, Gorak-Stolinska P, Ben-Smith A, et al. The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 months. Vaccine 2006; 24: 2617-26.